| Factors Affecting Production of C-reactive Protein in Vascular Smooth Muscle Cells |
| Seung-Jung Kim, M.D., Dong-Ryeol Ryu, M.D., Duk-Hee Kang, M.D. and Kyu-Bok Choi, M.D. |
| Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, Korea |
| 임상연구 : 혈관 평활근세포 내 CRP 생성에 영향을 미치는 물질에 대한 연구 |
| 김승정, 류동열, 강덕희, 최규복 |
| 이화여자대학교 의학전문대학원 내과학교실 |
|
|
| Abstract |
|
Purpose:The stenosis of vascular access for hemodialysis is caused by neointimal hyperplasia with the proliferation of vascular smooth muscle cells (SMC) as a prominent feature. C-reactive protein (CRP) is known to be produced in vascular SMC and can promote SMC proliferation. However, it is unclear of which factors regulate CRP production in neointimal hyperplasia. In the present study, we evaluated the factors affecting production of CRF in aortic SMC.
Methods:Human aortic SMC were cultured in a American type culture collection (ATCC) medium containing 10% FBS. Platelet-derived growth factor (PDGF) (10, 100 ng/mL), interferon-γ (INF-γ) (1, 10, 100 ng/mL), hydroxymethylglutaryl-coA reductase inhibitor (lovastatin) (10 µM/L) were added. After 72 hours, the level of CRP in SMC was measured by Western blot analysis and cell proliferation was assessed by MTT dye reduction assay. We used RT-PCR to observe PDGF receptor expression in SMC.
Results:Both INF-γ and PDGF were found to stimulate CRP production and SMC proliferation. In contrast, lovastatin inhibited PDGF or INF-γ induced CRP production and SMC proliferation. The expression of PDGF receptor-α in aortic SMC was increased after treatment of 100 ng/mL of IFN-γ.
Conclusion:SMC proliferation and CRP production in SMC are stimulated by PDGF or INF-γ and inhibited by statin. |
| Key Words:
C-reactive protein, Smooth muscle, Platelet-derived growth factor, Interferon-γ, Hydroxymethylgluta |
|
PDF Links
Download Citation
